Literature DB >> 32122272

Targeting Integrins with Radiolabeled RGD Analogues for Radiotheranostics of Metastatic Radioactive Iodine Nonresponsive Thyroid Cancer: New Avenues in Personalized Medicine.

Joanna Klubo-Gwiezdzinska1, Xiaoyuan Chen2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32122272      PMCID： PMC7187961          DOI： 10.1089/thy.2020.0169

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  15 in total

1.  Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.

Authors:  Yong-Il Kim; Hai-Jeon Yoon; Jin Chul Paeng; Gi Jeong Cheon; Dong Soo Lee; June-Key Chung; E Edmund Kim; Woo Kyung Moon; Keon Wook Kang
Journal:  Clin Nucl Med       Date:  2016-08       Impact factor: 7.794

2.  End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma.

Authors:  Warren P Mason
Journal:  Neuro Oncol       Date:  2015-02-13       Impact factor: 12.300

3.  Usefulness of 68Ga-DOTA-RGD (αvβ3) PET/CT Imaging in Thyroglobulin Elevation With Negative Iodine Scintigraphy.

Authors:  Rakhee Vatsa; Jaya Shykla; Bhagwant Rai Mittal; Priya Bhusari; Apurva Sood; Rajender Kumar Basher; Anish Bhattacharya
Journal:  Clin Nucl Med       Date:  2017-06       Impact factor: 7.794

4.  Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines.

Authors:  S Hoffmann; K Maschuw; I Hassan; B Reckzeh; A Wunderlich; S Lingelbach; A Zielke
Journal:  Thyroid       Date:  2005-09       Impact factor: 6.568

5.  68Ga-DOTA-RGD2 Positron Emission Tomography/Computed Tomography in Radioiodine Refractory Thyroid Cancer: Prospective Comparison of Diagnostic Accuracy with 18F-FDG Positron Emission Tomography/Computed Tomography and Evaluation Toward Potential Theranostics.

Authors:  Ashwin Singh Parihar; Bhagwant Rai Mittal; Rajender Kumar; Jaya Shukla; Anish Bhattacharya
Journal:  Thyroid       Date:  2020-01-23       Impact factor: 6.568

6.  Combined 68Ga-NOTA-PRGD2 and 18F-FDG PET/CT Can Discriminate Uncommon Meningioma Mimicking High-Grade Glioma.

Authors:  Deling Li; Jingjing Zhang; Nan Ji; Xiaobin Zhao; Kun Zheng; Zhen Qiao; Fang Li; Lixin Lang; Andrei Iagaru; Gang Niu; Zhaohui Zhu; Xiaoyuan Chen
Journal:  Clin Nucl Med       Date:  2018-09       Impact factor: 7.794

7.  RGD PET: From Lesion Detection to Therapy Response Monitoring.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-11-25       Impact factor: 10.057

8.  68Ga-BBN-RGD PET/CT for GRPR and Integrin αvβ3 Imaging in Patients with Breast Cancer.

Authors:  Jingjing Zhang; Feng Mao; Gang Niu; Li Peng; Lixin Lang; Fang Li; Hongyan Ying; Huanwen Wu; Boju Pan; Zhaohui Zhu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

9.  Clinical study of 99mTc-3P-RGD2 peptide imaging in osteolytic bone metastasis.

Authors:  Guoqiang Shao; Wei Gu; Muhong Guo; Shiming Zang; Jinjing Fu; Shuang Liu; Feng Wang; Zizheng Wang
Journal:  Oncotarget       Date:  2017-04-27

Review 10.  Every step of the way: integrins in cancer progression and metastasis.

Authors:  Hellyeh Hamidi; Johanna Ivaska
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716
View more
  6 in total

1.  IVUS\IVPA hybrid intravascular molecular imaging of angiogenesis in atherosclerotic plaques via RGDfk peptide-targeted nanoprobes.

Authors:  Lejian Lin; Zhihua Xie; Mengqi Xu; Yabin Wang; Sulei Li; Ning Yang; Xiaojing Gong; Ping Liang; Xu Zhang; Liang Song; Feng Cao
Journal:  Photoacoustics       Date:  2021-03-18

2.  Investigation of the Presence of Integrin Alpha-3 and Beta-1 Receptors on Tumor Tissue, Metastatic Lymph Node and Normal Tissue in Thyroid Cancer.

Authors:  Esra Arslan; Tamer Aksoy; Taha Cumhan Şavlı; Didem Can Trabulus; Ahmet Volkan Sünter; Tevfik Fikret Çermik
Journal:  Mol Imaging Radionucl Ther       Date:  2022-06-27

Review 3.  Translating Molecules into Imaging-The Development of New PET Tracers for Patients with Melanoma.

Authors:  Laetitia Vercellino; Dorine de Jong; Laurent Dercle; Benoit Hosten; Brian Braumuller; Jeeban Paul Das; Aileen Deng; Antoine Moya-Plana; Camry A'Keen; Randy Yeh; Pascal Merlet; Barouyr Baroudjian; Mary M Salvatore; Kathleen M Capaccione
Journal:  Diagnostics (Basel)       Date:  2022-04-29

Review 4.  Theranostic Options for Radioiodine-Refractory Differentiated Thyroid Carcinoma: Recent Advances, Challenges, and Road Ahead.

Authors:  Swayamjeet Satapathy; Chandrasekhar Bal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-12       Impact factor: 6.055

5.  Multimodal Imaging of Target Detection Algorithm under Artificial Intelligence in the Diagnosis of Early Breast Cancer.

Authors:  Meiping Jiang; Sanlin Lei; Junhui Zhang; Liqiong Hou; Meixiang Zhang; Yingchun Luo
Journal:  J Healthc Eng       Date:  2022-01-10       Impact factor: 2.682

6.  Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery.

Authors:  Xiaolin Yu; Lu Xue; Jing Zhao; Shuhua Zhao; Daqing Wu; Hong Yan Liu
Journal:  Pharmaceutics       Date:  2021-12-17       Impact factor: 6.525
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.